Eli Lilly and Company
Corprate Bias Ratings
Eli Lilly and Company vets vendors according to LGBTQ policies and does not provide its employees with protections against viewpoint discrimination. However, it has not publicly terminated business relationships based on views or beliefs. The company covers the cost of "medically necessary transition-related care" for its employees and their children. The company pledged $25 million to BLM and related causes and denounced religious freedom legislation. Eli Lilly has also spoken out against state efforts to reform its own election processes. The company has funded Planned Parenthood and multiple LGBT organizations. However, it has not used its PAC contributions for ideological purposes. For these reasons, Eli Lilly receives a Medium Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
The Lilly Foundation matches employee donations to health, education, and culture organizations. Contributions made “primarily for religious purposes” or to organizations that “promote religion” are ineligible (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Eli Lilly advocates for the Equality Act (1). Eli Lilly put out a commercial featuring a seemingly transgender man and uses the language, “the body you are randomly assigned at birth shouldn’t determine how well you are cared for” (2). The company also spoke out against Indiana’s state legislature revising election procedures after the pandemic and against the state’s religious freedom restoration act law in 2015 (3). The company criticized the state’s abortion ban, saying “that it would be forced to look outside the state for employment growth” (4).
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Eli Lilly has a perfect score on the HRC’s 2022 Corporate Equality Index. This score indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2). Eli Lilly has previously funded Planned Parenthood (3). It is unclear if the company is currently supporting the organization. Eli Lilly has pledged $25 million to the Black Lives Matter movement and related causes (4)(5). Eli Lilly is a copper sponsor of Out & Equal and a corporate partner of the National LGBT Chamber of Commerce (6)(7).
All links were last accessed and all information was updated on:
August 28, 2023
Company reports are intended for educational use only. Full Disclaimer
|Date||ESG Category||Proponent||Summary of Resolution||Mgmt Rec||Total Vote % in Favor|
|5/1/23||Social||National Center for Public Policy||Report on Risks of Supporting Abortion||Against||1.90%|
|5/1/23||Governance||SEIU Master Trust||Report Disclosing Lobbying Activity||Against||31.40%|
|5/1/23||Social||Trinity Health||Report on Impact of Patent Process on Product Access||Against||10.40%|
|5/1/23||Social||As You Sow||Report on the Effectiveness of the Company's Diversity, Equity, and Inclusion Efforts||Against||27.10%|
|5/1/23||Social||As You Sow, on behalf of Leslie Oelsner Bene IRA of S Berman (S), Sarah B Sonnenfeld Rev Tr (S), Curtis Overway and Marcelina Cravat-Overway||Greater Disclosure of Material Corporate Diversity||Against||27.10%|
|5/1/23||Governance||John Chevedden||Eliminate Supermajority Voting Requirements||Against||40.70%|
|5/1/23||Governance||CommonSpirit Health||Report on Lobbying Values Congruency||Against||22.50%|
|5/1/23||Governance||Change Finance||Require Indirect Political Spending Reporting||Against||4.10%|
|5/2/22||Governance||Legal & General Invest. Mgmt. America, Inc.||Independent Board Chair||Against||34.54%|
|5/2/22||Social||CommonSpirit Health||Disclose Lobbying Activities & Alignment with Public Policy Positions||Against||34.00%|
|5/2/22||Governance||Trinity Health||Report Oversight of Risks Related to Anticompetitive Pricing Strategies||Against||22.78%|
|5/2/22||Social||SEIU Master Trust||Report on Lobbying Payments and Policy||Against||37.03%|